e-learning
resources
Virtual 2021
06.09.2021
Lung disease burden and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Estimating the prevalence of undiagnosed inducible laryngeal obstruction within a severe asthma cohort
E. Akerman (Birmingham, United Kingdom), N. Atkins (Birmingham, United Kingdom), B. Sutton (Birmingham, United Kingdom), N. Pargeter (Birmingham, United Kingdom)
Source:
Virtual Congress 2021 – Lung disease burden and management
Session:
Lung disease burden and management
Session type:
E-poster
Number:
2142
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Akerman (Birmingham, United Kingdom), N. Atkins (Birmingham, United Kingdom), B. Sutton (Birmingham, United Kingdom), N. Pargeter (Birmingham, United Kingdom). Estimating the prevalence of undiagnosed inducible laryngeal obstruction within a severe asthma cohort. 2142
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD
Source: Eur Respir J, 56 (5) 2003574; 10.1183/13993003.03574-2020
Year: 2020
Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD
Source: Eur Respir J, 56 (5) 2003367; 10.1183/13993003.03367-2020
Year: 2020
Incidence and risk factors of chronic airway obstruction (ACOS) in a population-based asthma cohort
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017
Prevalence and risk factors of fixed airway obstruction in children with asthma
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
Prevalence of coexistent airways obstruction in patients with cardiac disease
Source: Eur Respir J 2004; 24: Suppl. 48, 278s
Year: 2004
Twelve-year asthma incidence in asymptomatic bronchial responsiveness in adults and children from the EGEA study
Source: Annual Congress 2007 - Risk factors for prevalence and incidence of asthma
Year: 2007
Significance of persistent airflow obstruction in patients with severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 406s
Year: 2002
Prevalence of pre-operative airflow obstruction in high risk patients without prior COPD diagnosis
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021
Risk factors for severe bronchial asthma in young adults with childhood-onset asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
Prevalence and 20-year trends of chronic bronchitis, bronchial obstruction and asthma in Finland
Source: Eur Respir J 2003; 22: Suppl. 45, 117s
Year: 2003
Detecting patients at risk of developing airflow obstruction in general population
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007
Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021
Predictors of mortality in elderly subjects with and without chronic airflow obstruction
Source: Eur Respir J 2001; 18: Suppl. 33, 506s
Year: 2001
The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017
Clinically remitted childhood asthma is a risk factor for airflow obstruction in middle-aged adults
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Predictors of exercise-induced airways obstruction in patients with mild asthma.
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020
Prevalence and under-diagnosis of chronic airflow obstruction in the French population visiting prevention centres
Source: Eur Respir J 2005; 26: Suppl. 49, 592s
Year: 2005
Impact of COVID-19 side-effects on pediatric and adult patients with recurrent wheeze and asthma
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021
Investigation of the prevalence of undiagnosed airflow obstruction in symptomatic subjects attending a large physiotherapy department
Source: Eur Respir J 2005; 26: Suppl. 49, 181s
Year: 2005
Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept